Contrasting Solesence (SLSN) and Its Competitors

Solesence (NASDAQ:SLSN) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it compare to its competitors? We will compare Solesence to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Profitability

This table compares Solesence and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Solesence	1.56%	5.39%	1.78%
Solesence Competitors	-6.02%	-112.34%	-0.10%

Risk & Volatility

Solesence has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, Solesence’s competitors have a beta of 0.79, indicating that their average stock price is 21% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Solesence and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1	0	0	0	1.00
Solesence Competitors	833	2778	3556	210	2.43

As a group, “Personal Care Products” companies have a potential upside of 2.40%. Given Solesence’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Solesence has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

70.2% of Solesence shares are owned by institutional investors. Comparatively, 48.7% of shares of all “Personal Care Products” companies are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Comparatively, 12.2% of shares of all “Personal Care Products” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Solesence and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Solesence	$62.06 million	$1.79 million	107.00
Solesence Competitors	$7.90 billion	$1.08 billion	5.58

Solesence’s competitors have higher revenue and earnings than Solesence. Solesence is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Solesence competitors beat Solesence on 7 of the 13 factors compared.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.